This announcement is a separate document:
贵州益佰制药股份有限公司董事会审计委员会对会计师事务所2023年年度履行监督职责情况报告
Report of the Audit Committee of the Board of Directors of Guizhou Yibai Pharmaceutical Co., Ltd. on the performance of supervisory duties by the accounting firm in 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.